Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18371435 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease
Condition: Chronic Graft Versus Host Disease
Interventions: Biological: Biological: mesenchymal stem cell;   Drug: Cyclosporine and Glucocorticoid
2 Recruiting Mesenchymal Stem Cells Treat Liver Cirrhosis
Condition: Liver Cirrhosis
Interventions: Drug: Conserved Therapy;   Procedure: Hepatic artery infusion or Intravenous infusion

Indicates status has not been verified in more than two years